TSMHT
ZYME icon

Thurston Springer Miller Herd & Titak’s Zymeworks ZYME Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-610
Closed -$16.1K – 1430
2025
Q4 		$16.1K Buy
+610
New +$13.3K 0.01% 812

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ZYME Position: Q1 2026 in Review

Thurston Springer Miller Herd & Titak sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 610 shares — an estimated $16.1K sold.

Thurston Springer Miller Herd & Titak first reported a position in ZYME in Q4 2025 and held it in 1 quarter. The position peaked at $16.1K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Thurston Springer Miller Herd & Titak reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 610 Zymeworks shares in Q1 2026, an estimated $16.1K.
  • Thurston Springer Miller Herd & Titak first reported a position in Zymeworks in Q4 2025 and held it in 1 quarter.
  • Thurston Springer Miller Herd & Titak's Zymeworks position peaked at $16.1K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q1 2026, filed 14 Apr 2026.